-
1 Comment
IRadimed Corporation is currently in a long term uptrend where the price is trading 20.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.8.
IRadimed Corporation's total revenue sank by 21.5% to $9M since the same quarter in the previous year.
Its net income has dropped by 80.3% to $637K since the same quarter in the previous year.
Finally, its free cash flow fell by 35.7% to $2M since the same quarter in the previous year.
Based on the above factors, IRadimed Corporation gets an overall score of 2/5.
Exchange | NASDAQ |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
CurrencyCode | USD |
ISIN | US46266A1097 |
Market Cap | 678M |
---|---|
PE Ratio | 35.55 |
Target Price | 71 |
Dividend Yield | 1.3% |
Beta | 0.83 |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IRMD using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025